Search filters

List of works by Paul A Bunn

2020 Innovation Based Optimism for Lung Cancer Outcomes

scientific article published on 11 November 2020

A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer

scientific article

Characteristics of lung cancers harboring NRAS mutations

scientific article (publication date: May 2013)

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium

scientific article

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

scientific article

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

scientific article

Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer

scientific article

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

scientific article

In Reply

Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy

scientific article

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression

scientific article

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer ⬇️

scientific article published on December 1, 2012

Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status

scientific article published on 26 March 2016

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014

scientific article

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

scientific article published on May 2015

New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer

scientific article published on 25 January 2010

Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer ⬇️

scientific article published on January 26, 2012

Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.

scientific article

Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer

scientific article

Scientific Advances in Lung Cancer 2015.

scientific article published on 21 March 2016

Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer

scientific article

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.

scientific article published on 20 May 2016

The evolution of tumor classification: a role for genomics?

scientific article published on December 2013

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs

scientific article

Paulina is supported by:

About Paulina

Help